Previous studies have demonstrated that miltefosine can ameliorate atherosclerosis by promoting cholesterol efflux from macrophages, inhibiting NLRP3 inflammasome activation, and enhancing autophagy and mitophagy.29 Here, NLRP3 is linked to atherosclerosis.